These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 35628192)
1. Quest for Quality in Translational Stroke Research-A New Dawn for Neuroprotection? Haupt M; Gerner ST; Bähr M; Doeppner TR Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628192 [TBL] [Abstract][Full Text] [Related]
2. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers. Green AR; Ashwood T Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):109-18. PubMed ID: 15857295 [TBL] [Abstract][Full Text] [Related]
3. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke. Savitz SI Exp Neurol; 2007 May; 205(1):20-5. PubMed ID: 17408618 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches. Wahlgren NG; Ahmed N Cerebrovasc Dis; 2004; 17 Suppl 1():153-66. PubMed ID: 14694293 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotection for stroke: current status and future perspectives. Minnerup J; Sutherland BA; Buchan AM; Kleinschnitz C Int J Mol Sci; 2012; 13(9):11753-11772. PubMed ID: 23109881 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Strategies for Ischemic Stroke-Future Perspectives. Haupt M; Gerner ST; Bähr M; Doeppner TR Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901765 [TBL] [Abstract][Full Text] [Related]
7. Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke. Maples KR; Green AR; Floyd RA CNS Drugs; 2004; 18(15):1071-84. PubMed ID: 15581379 [TBL] [Abstract][Full Text] [Related]
9. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Philip M; Benatar M; Fisher M; Savitz SI Stroke; 2009 Feb; 40(2):577-81. PubMed ID: 19074479 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotection in stroke: the importance of collaboration and reproducibility. Neuhaus AA; Couch Y; Hadley G; Buchan AM Brain; 2017 Aug; 140(8):2079-2092. PubMed ID: 28641383 [TBL] [Abstract][Full Text] [Related]
11. Anesthetic neuroprotection: antecedents and an appraisal of preclinical and clinical data quality. Ishida K; Berger M; Nadler J; Warner DS Curr Pharm Des; 2014; 20(36):5751-65. PubMed ID: 24502575 [TBL] [Abstract][Full Text] [Related]
12. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Savitz SI; Fisher M Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989 [TBL] [Abstract][Full Text] [Related]
14. PRIMED Bahr-Hosseini M; Bikson M; Iacoboni M; Liebeskind DS; Hinman JD; Carmichael ST; Saver JL Transl Stroke Res; 2022 Apr; 13(2):222-227. PubMed ID: 34196953 [TBL] [Abstract][Full Text] [Related]
15. Life after cerovive: a personal perspective on ischemic neuroprotection in the post-NXY-059 era. Ginsberg MD Stroke; 2007 Jun; 38(6):1967-72. PubMed ID: 17478741 [TBL] [Abstract][Full Text] [Related]
16. Development of the nitrone-based spin trap agent NXY-059 to treat acute ischemic stroke. Lapchak PA; Araujo DM CNS Drug Rev; 2003; 9(3):253-62. PubMed ID: 14530797 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotection for ischaemic stroke: translation from the bench to the bedside. Sutherland BA; Minnerup J; Balami JS; Arba F; Buchan AM; Kleinschnitz C Int J Stroke; 2012 Jul; 7(5):407-18. PubMed ID: 22394615 [TBL] [Abstract][Full Text] [Related]
18. [Past, present and future of neuroprotection]. Mracek J Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585 [TBL] [Abstract][Full Text] [Related]